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Seventeen years of drug-resistant tuberculosis
in Argentinian children
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L. Casimir, C. Sarkis, D. Mecicovsky, M.T. Rosanova
Hospital de Pediatria JP Garrahan, Buenos Aires,
Argentina
Background: The emergence of strains of Mycobacterium tuber-
culosis (Mt) that are resistant to antimycobacterial agents (DR-TB)
is a worldwide problem of which the magnitude has not been well
described specially in pediatric patients. TB susceptibility surveil-
lance and risk factors for DR-TB are important issues to consider
at the moment of pediatric TB treatment. OBJECTIVE: To asses the
prevalence of DR- TB in children, and identify clinical features, risk
factors, and outcome of pediatric patients with DR-TB.
Methods & Materials: Retrospective review of all mycobac-
terial samples send to microbiological evaluation from 1998 to
2015 at Hospital PediatríaGarrahan. We analyzed 46 patients (p),
with microbiological conﬁrmation of DR-TB. Resistance tests to
ﬁrst line drugs: Isoniazid (INH), Rifampicin (RMP) Pyrazinamide
(PZ), Ethambutol (EMB), Streptomycin (STO) were performed on
Lowenstein- Jensen medium and BACTEC 460 TB system. We
deﬁned DR-TB at those strains of Mt resistant to one or more ﬁrst-
line drugs. We divided into single or resistant to 2 or more drugs.
In the latter group, we recorded the data in two mutually exclusive
categories: multidrug resistant TB strains (MDR-TB, those resistant
to at least INH+RMP), and resistant to 2 or more drugs (other than
INH+RMP)
Results: We included 1195 TB p, 478 bacteriologically positive
conﬁrmed culture. Forty six strains (9.6%) were DR-TB. Primary
resistance was found in 39/46 (85%). The median age was 130
months (r: 2-204),16 (35%) were immunocompromised, 75% of
whom HIV positive. Pulmonary disease was the most common
presentation: 29 p (60%). Eighteen p (40%) had extra-pulmonary
localization. Of 46 DR-TB cultures 28 (60%) were monorresistant
and 18 (40%) resistant to 2 o more drugs. Ten were MDR-TB 8 of
who hadHIV infection.Monorresistance for INH, RMP, PZ, EMB and
STO were 1.6% 0.2%, 0%, 0.2% and 4% respectively. Resistance to
INH was 3%. Fourteen p (30%) had TB contact, 9 (19%) had previ-
ous hospital admission, and 7 (15%) previous TB treatment. Three
p (6%) died because of TB, all of them with central nervous system
infection.
Conclusion: DR-TB is infrequent in pediatric patients. MR-TB is
associatedwithHIV. INH resistancewas present in 3% of all isolated
strains.
http://dx.doi.org/10.1016/j.ijid.2016.02.828
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Early cardiac safety of the 9-11 month Short
course regimen for MDR-TB treatment
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Background: Only 48% of multidrug resistant tuberculo-
sis (MDR-TB) patients worldwide receive successful outcomes.
Shorter, more effective regimens are required. The cardiac safety of
the 9-11 month “Bangladesh regimen” has been largely unstudied.
The regimenwaspiloted inUzbekistan andasperWHOrecommen-
dations, electrocardiographic (ECG) monitoring was performed in
the early phase of treatment. We aim, in this interim analysis, to
describe the early cardiac safety of this regimen.
Methods & Materials: Consecutively diagnosed MDR patients
were recruited from Karakalpakstan, Uzbekistan. Moxiﬂoxacin
400mg and clofazimine 100mg daily were included in the regi-
men. Patients had a single, 12 lead ECG performed at baseline, 2
and 4 weeks of therapy. RR and QT interval length was measured
using lead II or V2 on the ECG printouts. QT was corrected using
Fridericia’s formula (QTcF). Data was prospectively collected using
a standardised database (Koch 6, MSF, Paris) and analysed using
openEpi (Ver 3.03, accessed 26/7/2015).
Results: Between September 2013 and March 2015, 146
patients were enrolled. No patients were excluded from the study
due to baseline cardiac ﬁndings or QT prolongation. Of these, 121
had ECGs performed per protocol and available for analysis. 27
(22.3%) were over 50 years of age and six had a reported history
of cardiac disease. 12 patients (9.9%) had increases >60 ms from
baseline with 1 patient showing an increase at both time points.
Only one of these patients had QTcF increased over 450 ms. No
patients hadQTcF >500msduring the screening period. Nopatients
reported syncope or seizures and there were no deaths during the
screening period. Univariate analysis of those with QT prolonga-
tion versus no QT prolongation did not identify other signiﬁcant
risk factors.
Table 1 - ECG data
388 17th International Congress on Infectious Diseases / International Journal of Infectious Diseases 45S (2016) 1–477
Table 2 - Univariate analysis of cohort with QT prolongation
vs. no QT prolongation
Conclusion: Our results suggest that a 9-11 month regimen has
acceptable early cardiac safety. As expected, QTcF is prolonged, the
signiﬁcance of which in MDR-TB patients requires further investi-
gation.
http://dx.doi.org/10.1016/j.ijid.2016.02.829
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Detection of mycobacterium leprae in tissue
sections using auramine O ﬂuorescent stain
versus modiﬁed ﬁte-faraco: A comparative
study
K. Bhardwaj ∗, S. Ghate, R. Dhurat
Lokmanya Tilak Municipal General Hospital and
Lokmanya Tilak Municipal Medical College, Sion
Mumbai, Mumbai, India
Background: Modiﬁed Fite-Faraco method is commonly used
for detection of lepra bacilli in the tissue samples. Recently, ﬂu-
orescence microscopy have provided enhanced sensitivity and
speciﬁcity over those of the conventional tehcniques especially
when lepra bacilli numbers in tissue specimens were low. The
present studywas initiated to compare conventionalModiﬁed ﬁte-
faraco based detection of lepra bacilli detection with Auramine
stain-based ﬂuorescence microscopy.
Methods & Materials: One hundred eighteen skin biopsies was
obtained from patients clinically diagnosed as leprosy. Diseasewas
classiﬁed into Indeterminate (I)(n=28),Tuberculoid (TT=2), Bor-
derline tuberculoid (BTH,n=67), Borderline borderline (BB,n=2),
Borderline Lepromatous (BL)(n=13) and Lepromatous (LL,n=6).
Each biopsy was stained by Auramine and Modiﬁed Fite-Faraco.
The sections was screened for the detection of lepra bacilli. Sec-
tions stained by Auramine was seen under Fluorescent microscope
which showed bright yellow rods against dark background.
Results: Out of 118 biopsies, 75 were positive by Auramine
while only 41 by Modiﬁed Fite- faraco. Out of 28 Indeterminate
cases 12(42.9%) showed bacilli by Auramine and 2(7.1%) by Mod-
iﬁed Fite-Faraco. 42(62.7%) out of 67,and 20(29.9%) out of 67
BTH patients were positive by Auramine and Modiﬁed Fite-Faraco
respectively. Biopsies fromBBwerepositivebyboth themethods.In
BL/LL Modiﬁed Fite-Faraco detected bacilli in 11 out of 13(84.6%)
and all 6(100%) respectively while Auramine detected bacilli in all
19(100%)BL/LL biopsies.
Conclusion: Auramine and Modiﬁed Fite-Faraco are equally
sensitive for detecting lepra bacilli in lepromatous pole. The
Auraminemethodwas found to be superior toModiﬁed Fite-Faraco
especially in early spectrum of leprosy.
http://dx.doi.org/10.1016/j.ijid.2016.02.830
Type: Poster Presentation
Final Abstract Number: 43.093
Session: Poster Session III
Date: Saturday, March 5, 2016
Time: 12:45-14:15
Room: Hall 3 (Posters & Exhibition)
Curvilinear scars indicator of Lucio’s
phenomenon in leprosy
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Background: Lepromatous leprosy may present two types of
vasculonecrotic reactions. Lucio’s phenomenon and that associated
with ENL.We present a case of lepromatous leprosy that developed
Lucio phenomenon and ENL
Methods & Materials: A 28yr old male complained of asymp-
tomatic red raised lesions over body since 1 ½ months which
subsided with atrophic scars. He had past history of recurrent
evanescent painful nodules.
On examination multiple curvilinear jagged atrophic scars with
surrounding halo of hypopigmentation were seen over arms, fore-
arms, and legs.Multiple thickened nerveswere present. Sensations
were normal except for decrease in temperature and hot-cold on
medial aspect of the left palm.
Punch biopsy from the margin of a scar showed leukocy-
toclastic vascultis,thombosed blood vessels,inﬁltration of histio-
cytes,Langerhans giant cells in dermis, and AFB in endothelium on
Modiﬁed Fite Faraco staining. Another punch biopsy from a newly
developed nodule showed obliterative granulomatous medium
vessel vasulitis with presence of AFB in endothelium on Modiﬁed
Fite Faraco staining. Slit skin smear showed 4+ BI on average. After
a month of starting MDT and systemic steroids,patient developed
multiple ENL, which subsided with appropriate treatment
Results: Based on characterstic curvilinear scars, small and
medium sized vasculitis and presence of AFB globi in endothe-
lium, a primary diagnosis of Lucio’s phenomenon was made. After
a month of starting MDT and systemic steroids, patient developed
multipleENL,which subsidedwithappropriate treatment. Soaﬁnal
diagnosis was coexisting Lucio phenomenon and ENL in leproma-
tous leprosy
Conclusion: Lucio’s Phenomenon is very rarely reported from
India. We report this case to highlight the difﬁculties in differenti-
ating LP from necrotic ENL.
http://dx.doi.org/10.1016/j.ijid.2016.02.831
